Investigators retrospectively analyzed 451 patients who underwent allogeneic hematopoietic cell transplantation for AML in complete remission with either reduced intensity conditioning or myeloablative with the use of dual T cell depletion as graft-versus-host disease prophylaxis.
[European Journal Of Haematology]